MONTREAL, Nov 18 (LifeSiteNews.com) – The latest development in new reproductive technology, in-vitro maturation (IVM), sets the stage for the use of ova from aborted babies in fertility treatments. Dr. Seang Lin Tan of McGill University’s Reproductive Centre reported yesterday that he was the first doctor in Canada to successfully perform the procedure wherein women’s ova are matured outside the woman’s body in the lab by subjecting them to hormones. The traditional method of in-vitro fertilization had the ova matured inside the ovaries by administering hormones to the woman.
Health writer Susan Martinuk wrote in the National Post in September that “the ovaries of unborn females are filled with more eggs than those of a young girl or fertile woman because the number of eggs is maximal prior to birth and then declines from birth onwards…. Although the eggs are immature, they develop when subjected to the right hormones.” The IVM process will thus increase demand for the use of ova from aborted baby girls in fertility treatments.
Professor Roger Gosden, formerly of Leeds University in Britain, pioneered a procedure using the ova of aborted baby girls in fertility treatments before his research was criminalized in England. Last month, Gosden took up a post Canada – in fact, at McGill University where yesterday’s IVM procedure was announced – noting his disgust with Britain’s “more cautious attitude toward science and technology.”
With files from CBC.